Adam Roseman Online

The Healthy Habits for Kids workshops are part of Cedars-Sinai Medical Center’s efforts to prevent obesity. This ten-week program is offered in schools in the Los Angeles area, and focuses on encouraging children to eat well and exercise regularly by instilling these habits at a young age. The program believes that healthy habits begin through curiosity, and therefore the health educators make sure to include the children, answer questions and pique their interest.

Cedars-Sinai Medical Center, where Adam Roseman is a member of the board, is an organization which works to provide high quality healthcare and state-of-the-art medical research.

Nine years ago, Cedars-Sinai Medical Center’s Maxine Dunitz Neurosurgical Institute discovered a small change which occurs in the molecular structure of the most violent type of brain tumor; the glioblastoma multiforme. When they dug deeper, they detected that a specific protein called laminin- 411 supports the building of the tumor’s new blood vessels, which enable its widespread growth. At the time, there was no technology available that could block this protein.

Recently, a research team from Cedars-Sinai, which is a non-profit organization where Adam Roseman is a board member, has created a drug which is injected into the bloodstream and carried to the tumor. The drug is triggered by the different pH level in the cancerous cells, and blocks the tumor cells’ production of the harmful laminin-411 protein. This new method is regarded as the first of its kind.

A new surgical imaging device was recently developed and tested in Cedars- Sinai Medical Center, where Adam Roseman is a member of the board of governors. The new scope, called a VITOM, was studied by Neurosurgeon Adam N. Mamelak M.D. , who is practiced in minimally invasive pituitary surgery and is co-director of the Pituitary Center at Cedars-Sinai. During his inspection of the device, Dr. Mamelak was asked by veterinary endocrinologists and surgeons from VCA West Los Angeles Animal Hospital if it could be used in similar operations for animals. Some pituitary tumors are very common in dogs, and are often fatal.

After further examining the scope, Mamelak found that it could indeed be used for animal neurosurgery as well. He agreed to teach the veterinary surgeons how to use it while performing life-saving operations to remove the tumors. The surgery benefits both humans and dogs in an additional way; the removed tumors are sent back to the Cedars-Sinai labs for further examination and testing, with hopes of discovering a drug that can be used as a non-invasive cure.

There is currently only one other organization, located in the Netherlands, working to surgically remove pituitary tumors in canines. Both groups use a transsphenoidal approach, which is basically creating a small hole at the back of the mouth in order to enter the skull at the base of the brain. This has been only partially effective in veterinary surgery until now, because dogs have long snouts which make it harder for the surgeons to see what they are doing. The VITCOM is a wonderful solution to this problem, as it magnifies the operation field by up to 12 times.

Adam Roseman, Founder and Managing Director of ARC China, announced on September 20, 2010 that he would be moderating a panel discussion.  The panel discussion, titled “Examining the Development & Growth of a Sustainable Domestic Private Equity & Venture Capital Ecosystem In China: What More Is Needed For The Long Term Strength Of The Industry?” was part of the China Summit at SuperReturn Asia 2010.

SuperReturn Asia 2010 is the region’s main annual Private Equity and Venture Capital Industry event, and it was co-sponsored this year by Adam Roseman’s investment firm, ARC China.  This year’s conference was held from September 27-30 at the JW Marriot Hotel in Hong Kong.

The panel examined a number of current topics including exit strategies and the need for transparency in China’s domestic listing process.

SuperReturn Asia is the premier  conference, held annually, which examines the Private Equity and Venture Capital Industry in China and Asia. This year’s conference took place on September 27-30, 2010 and was co-sponsored by the investment firm ARC China. Adam Roseman, the founder and managing Director of ARC China, was the moderator for an informative panel discussion investigating a particular aspect of the private equity and venture capital industry entitled, “Examining The Development & Growth Of A Sustainable Domestic Private Equity & Venture Capital Ecosystem In China: What More Is Needed For The Long Term Strength Of The Industry?”

This panel discussion was part of the popular “China Summit,” one of the  events at the SuperReturn Asia 2010 conference. The panel looked at many relevant subjects that are of interest, including exit strategies and the importance and need for transparency in the domestic listing process in China. Also discussed were ways to expand mainstream securities and other financial structures, the growth and change of the legal and educational institutions which are critical for the support of China’s growing private equity industry, and other crucial subjects.

The end of September, 2010 saw Adam Roseman once again involved in an informative panel discussion entitled “Examining The Development & Growth Of A Sustainable Domestic Private Equity & Venture Capital Ecosystem In China: What More Is Needed For The Long Term Strength Of The Industry?” The panel discussion, which was moderated by Roseman, founder and managing director of ARC China, took place during the China Summit at SuperReturn Asia 2010, which was held from September 27-30.

SuperReturn Asia is the flagship conference held annually which takes an in-depth look at the past, present and future of the private equity and venture capital industry in China and the rest of Asia.  ARC China, Adam Roseman’s firm, was a co-sponsor of this influential and well-attended conference.

Adam Roseman, Founder and Managing Partner at ARC China, explains in his weekly newsletter that China is promoting strategies to develop seven emerging industries.  These industries include energy saving and environmental protection, new generation of information technology, biology, high-end equipment manufacturing, new energy, new material, and alternative energy vehicles.

The State Council selected these seven industries recently during an executive meeting.  Shortly thereafter, the National Development and Reform Commission (NDRC), China’s top economic planner, announced a plan to invest RMB100 billion in these emerging industries.  This money should be put into these seven strategic industries over the next two to three years.

Adam Roseman was a panelist speaking on RMB Funds’ exit strategies at the recent 2010 China RMB Funds Forum in his capacity as ARC China MD and founder.  It is ARC China that has launched six public-private joint equity RMB funds so far.  The firm has also joined forces with The Westly Group (a venture capital firm) and local governments to set up funds in Tier II and Tier III cities in the hope of supporting and developing the local economies.  In this capacity it aims to “conduct due diligence, market analysis, transaction negotiation, corporate governance advisory for portfolio companies, and thorough analyses of exit opportunities to determine the suitability of potential enterprises.”  Roseman asserted that: “It is important for PE funds in China to develop a multi-strategy exit approach to their portfolio companies.  While historically most PE portfolios in China have focused on a small number of portfolio companies providing the overwhelming return to their LPs through A-share listings, this is not healthy or sustainable over the longer-term.”

Before venturing into new investments, it’s important to take the time to get to know the market.  Certainly, companies like ARC China with Adam Roseman understand the Chinese market and have done their research before investing.

Here are a few suggestions.  To begin investing seriously in China, it is helpful to establish a local presence and to acquire local knowledge.  You can do so by establishing a representative office in China, or by teaming up with a partner that already lives there.  Consider incorporating Chinese expertise and local talent into your management plan.

Help top management to nurture close relationships with local counterparts.  They need to invest time and money into building strong relationships with business partners in the region.

Piper Jaffray Companies recently announced a net income of $7.4 million, or $0.36 per diluted common share, for the second quarter which ended June 30, 2010.  This is a significant decrease for the figures for the first quarter of the year when figures were $127.7 million. The company’s chairman and CEO Andrew S. Duff, commented: “We had mixed performance for the quarter. We generated solid investment banking results attributable to equity financing and advisory fee revenues. These results were partially offset, however, by significantly lower fixed income revenues driven by very challenging trading conditions in the second quarter.” When working in the West Coast Corporate Finance Group at Goldman, Sachs & Co. in San Francisco, Adam Roseman was advising fortune 500 clients on their strategic mergers and acquisitions initiatives and in the Technology Investment Banking Group at US Bancorp Piper Jaffray in Menlo Park.